Month: May 2024

54% complete response (CR) rate at 24-month landmark and meets primary endpoint of the phase 2 study IRVINE, Calif., May 24, 2024 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder cancer, today announced final results from the Phase 2 CORE-001 clinical trial of its oncolytic immunotherapy candidate, cretostimogene, in combination with pembrolizumab for the treatment of BCG-Unresponsive, High-Risk Non-Muscle Invasive Bladder Cancer (HR-NMIBC) with Carcinoma in Situ (CIS). The data will be presented at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting from May 31-June 4, in Chicago, IL. “There is a significant unmet need for new and innovative treatments...

PRESS RELEASE Luxembourg, 24th May 2024 VELCAN HOLDINGS: CONVENING NOTICE OF THE ORDINARY ANNUAL GENERAL MEETING TO BE HELD ON 27th JUNE 2024 VELCAN HOLDINGS announces to the shareholders of the Company that the Ordinary Annual General Meeting will be held on Thursday the 27th of June 2024, at 3 p.m, in the offices of the law firm Tabery & Wauthier, 10 rue Pierre d’Aspelt, L‐1142 Luxembourg, in order to vote mainly on the approval of the 2023 condensed non-audited consolidated financial statements and of the 2023 audited statutory financial statements; All required information and related documents will be available for downloading on the Company’s website on 24th May 2024:Convening notice of the Ordinary Annual General Meeting; Board of Directors’ report on the resolutions proposed to the General Meeting; Text of the proposed resolutions; Single...

Oslo, 24 May 2024. The Annual General Meeting in PCI Biotech Holding ASA took place today, 24 May 2024. All the matters on the agenda were approved and the minutes of the Annual General Meeting are attached to this release and are available on www.pcibiotech.com. Contact information:     PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo         Ronny Skuggedal, CEO / CFO, rs@pcibiotech.no, Mobile: +47 9400 5757 This information is subject to a duty of disclosure pursuant to Section 5-12 of the Norwegian Securities Trading Act.AttachmentPCI Biotech Holding ASA Minutes AGM 24 May 2024

VANCOUVER, British Columbia, May 24, 2024 (GLOBE NEWSWIRE) — NorthWest Copper Corp. (TSXV: NWST) (“NorthWest” or the “Company”) is pleased to announce that Enrico De Pasquale has been appointed to the Company’s Board of Directors effective May 23, 2024. Mr. De Pasquale is a lawyer and executive with an established record of advising, leading and transforming companies across multiple industries. He has extensive experience in strategic planning, business development, financing and mergers/acquisitions, while achieving organizational success. He also serves on the Board of Directors of several private companies and community organizations including Humber River Health Foundation where he is Chair of the Governance and Nominating Committee.  As a member of Northwest’s Board of Directors, Mr. De Pasquale will also serve on the Board’s...

LARBERT, United Kingdom, May 24, 2024 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI or the Company), a leading independent bus and coach manufacturer and a leader in electric mass mobility solutions, subsidiary Alexander Dennis Limited (Alexander Dennis) today announced that it has received a firm order for 29 Enviro500 double deck buses from BC Transit in British Columbia, Canada. BC Transit is a provincial government corporation that provides planning, marketing, fleet, and funding support for all transit services in British Columbia outside of the Metro Vancouver region. BC Transit works in partnership with 59 local governments and operates 57 transit systems. The new Enviro500 will be built as part of the partnership between Alexander Dennis and Big Rig Manufacturing. They will be supported in...

Company Announcement Copenhagen, 24 May 2024 No. 23/2024 ISS and Barclays extend successful global contract with another 5 years ISS A/S, a leading workplace experience and facility management company, today announces the extension of its global integrated facility services contract with Barclays. ISS will now continue to provide services to Barclays on a global scale until end-2029. ISS and Barclays initiated the collaboration in 2012, and ISS will continue to provide a wide range of Integrated Facility Services, including cleaning, technical, support services, catering as well as workplace solutions across the bank’s facilities in the UK and Ireland, Continental Europe, the Americas, Middle East, India and Asia & Pacific. The annual revenue from the contract represents around 2.5% of Group revenue. With the new contract extension,...